1. Home
  2. TEVA
  3. TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on June 1, 2025

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
TEVA

GlobeNewswire

a day ago

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date
TEVA

GlobeNewswire

a day ago

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date

TEVA

Morningstar Research

2 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

TEVA

Morningstar Research

2 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target
TEVA

Insider Monkey

3 days ago

Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
TEVA

GlobeNewswire

3 days ago

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate
TEVA

Zacks

4 days ago

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate

TEVA

MT Newswires

4 days ago

Truist Securities Initiates Teva Pharmaceutical Industries at Buy With $25 Price Target

Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
TEVA

Motley Fool

4 days ago

Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead

Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408
TEVA

Insider Monkey

4 days ago

Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408

TEVA

MT Newswires

4 days ago

Teva Pharmaceutical Receives FDA Fast Track Designation for Drug to Treat Celiac Disease

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
TEVA

GlobeNewswire

4 days ago

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
TEVA

GlobeNewswire

4 days ago

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June

Why Is Teva Stock Trading Higher On Tuesday?
TEVA

Benzinga

5 days ago

Why Is Teva Stock Trading Higher On Tuesday?

TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock?
TEVA

Zacks

5 days ago

TEVA Stock Up Around 13% in a Month: Buy, Sell or Hold the Stock?

TEVA

MT Newswires

5 days ago

Teva Pharmaceutical Industries Begins Preclinical Testing of Inflammation Drug BD9

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
TEVA

GlobeNewswire

5 days ago

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

Regulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)
TEVA

Insider Monkey

6 days ago

Regulatory Shake-Up Led to the Sell Off in Teva Pharmaceutical Industries Limited (TEVA)

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes
TEVA

GlobeNewswire

10 days ago

Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes

Teva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 Billion
TEVA

Simply Wall St.

11 days ago

Teva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 Billion

TEVA

MT Newswires

11 days ago

Teva Pharmaceutical Prices Upsized $2.3 Billion Notes Offering

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
TEVA

GlobeNewswire

11 days ago

Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
TEVA

GlobeNewswire

11 days ago

Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy

TEVA

MT Newswires

13 days ago

Teva Pharmaceutical Plans Issuance of $2 Billion Equivalent of Senior Notes

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
TEVA

GlobeNewswire

13 days ago

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
TEVA

GlobeNewswire

13 days ago

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
TEVA

GlobeNewswire

16 days ago

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

17 days ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
TEVA

Zacks

17 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying
TEVA

Insider Monkey

18 days ago

Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
TEVA

ACCESS Newswire

18 days ago

Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

TEVA

Argus Research

19 days ago

Analyst Report: Teva Phar Inds Lt

TEVA

Argus Research

19 days ago

Market Update: TEVA, ODFL, UBER, NET

TEVA

Argus Research

19 days ago

Daily – Vickers Top Buyers & Sellers for 05/13/2025

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
TEVA

Motley Fool

19 days ago

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today

TEVA

MT Newswires

19 days ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,097,304, According to a Recent SEC Filing

Teva's Bold $700M Gamble: Will It Be Enough to Rescue Its Plummeting Stock?
TEVA

GuruFocus.com

19 days ago

Teva's Bold $700M Gamble: Will It Be Enough to Rescue Its Plummeting Stock?

TEVA

MT Newswires

20 days ago

Teva Pharmaceutical Industries Shares Rise After JPMorgan Upgrades Rating

TEVA

MT Newswires

20 days ago

JPMorgan Upgrades Teva Pharmaceutical Industries to Overweight From Neutral, Adjusts Price Target to $23 From $21

TEVA

Morningstar Research

22 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential
TEVA

Insider Monkey

23 days ago

Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential

Teva Pharmaceutical Industries (NYSE:TEVA) Settles Class-Action Lawsuit For US$2 Million
TEVA

Simply Wall St.

24 days ago

Teva Pharmaceutical Industries (NYSE:TEVA) Settles Class-Action Lawsuit For US$2 Million

TEVA

Morningstar Research

24 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

TEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up
TEVA

Zacks

24 days ago

TEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up

Teva Pharmaceutical Industries First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
TEVA

Simply Wall St.

24 days ago

Teva Pharmaceutical Industries First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Teva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in ...
TEVA

GuruFocus.com

24 days ago

Teva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in ...

Why Teva Pharmaceutical Industries Limited (TEVA) Skyrocketed On Wednesday
TEVA

Insider Monkey

24 days ago

Why Teva Pharmaceutical Industries Limited (TEVA) Skyrocketed On Wednesday

Teva Stock Jumps On Outlook. CEO Touts 'Real Clarity' On Future Profits.
TEVA

Investor's Business Daily

24 days ago

Teva Stock Jumps On Outlook. CEO Touts 'Real Clarity' On Future Profits.

Why Teva Pharmaceutical Stock Is Soaring Today
TEVA

Motley Fool

25 days ago

Why Teva Pharmaceutical Stock Is Soaring Today

TEVA

MT Newswires

25 days ago

Sector Update: Health Care Stocks Gain Wednesday Afternoon

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says
TEVA

Barrons.com

25 days ago

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says

TEVA

MT Newswires

25 days ago

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report
TEVA

Investor's Business Daily

25 days ago

Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report

TEVA

MT Newswires

25 days ago

Teva Pharmaceutical's Q1 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Updated

Teva Pharm first-quarter profit rise tops estimates
TEVA

Reuters

25 days ago

Teva Pharm first-quarter profit rise tops estimates

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
TEVA

GlobeNewswire

25 days ago

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
TEVA

GlobeNewswire

25 days ago

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

TEVA

Thomson Reuters StreetEvents

a month ago

Q1 2025 Corcept Therapeutics Inc Earnings Call

TEVA

Argus Research

a month ago

Wild April Restores Some Market Optimism

FDA approves Selarsdi injection as interchangeable with Stelara
TEVA

Pharmaceutical Technology

a month ago

FDA approves Selarsdi injection as interchangeable with Stelara

Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?
TEVA

Zacks

a month ago

Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?

TEVA

MT Newswires

a month ago

Sector Update: Health Care Stocks Decline Pre-Bell Monday

What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q1 Earnings
TEVA

Zacks

a month ago

What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q1 Earnings

TEVA

MT Newswires

a month ago

Sector Update: Health Care

TEVA

MT Newswires

a month ago

Teva, Alvotech Get FDA Approval for Selarsdi's Interchangeablity With Stelara

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
TEVA

GlobeNewswire

a month ago

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
TEVA

Zacks

a month ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

TEVA

Morningstar Research

a month ago

Analyst Report: Teva Pharmaceutical Industries Limited

Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now
TEVA

Motley Fool

a month ago

Trump Tariff Sell-Off: 3 Superb Stocks That Make for No-Brainer Buys Right Now

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals
TEVA

Zacks

2 months ago

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals

3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes
TEVA

Zacks

2 months ago

3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes

5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility
TEVA

Motley Fool

2 months ago

5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn
TEVA

Insider Monkey

2 months ago

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn

TEVA

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention
TEVA

Simply Wall St.

2 months ago

Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

2 months ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

TEVA

MT Newswires

2 months ago

Sector Update: Health Care Stocks Lean Lower Premarket Monday

TEVA

MT Newswires

2 months ago

Teva Rolls Out Lower-Cost Soliris Biosimilar in US

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Industries Says US FDA Accepted its sBLA Filing for AJOVY

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
TEVA

GlobeNewswire

2 months ago

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
TEVA

GlobeNewswire

2 months ago

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

TEVA

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva announces presentation of survey study on TEV-‘749
TEVA

TipRanks

2 months ago

Teva announces presentation of survey study on TEV-‘749

Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts?
TEVA

Insider Monkey

2 months ago

Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts?

TEVA

MT Newswires

2 months ago

Teva Says Schizophrenia Trial Survey Results Show Patient Satisfaction With TEV-'749

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
TEVA

GlobeNewswire

2 months ago

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical's Upcoming Cost-Optimization Plan May Offer Significant Benefits, UBS Says

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now
TEVA

Motley Fool

2 months ago

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now

Teva Releases Q1 2025 Aide Memoire
TEVA

GlobeNewswire

2 months ago

Teva Releases Q1 2025 Aide Memoire

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025
TEVA

GlobeNewswire

2 months ago

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks
TEVA

Motley Fool

2 months ago

Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks

Was Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?
TEVA

Insider Monkey

2 months ago

Was Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?

Teva Pharmaceutical Stock Scores RS Rating Upgrade
TEVA

Investor's Business Daily

2 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Teva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug Application
TEVA

Simply Wall St.

2 months ago

Teva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug Application

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
TEVA

PR Newswire

3 months ago

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

Teva debuts global campaign encouraging people to get outside
TEVA

Retail Dive

3 months ago

Teva debuts global campaign encouraging people to get outside

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $375,534, According to a Recent SEC Filing

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $999,425, According to a Recent SEC Filing

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $903,462, According to a Recent SEC Filing

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
TEVA

GlobeNewswire

3 months ago

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

Share on Social Networks: